Taigen Biopharmaceuticals Holdings Limit (太景医药研发控股股份有限公司) is an enterprise in Taiwan, China, with the main office in Taipei City. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on September 15, 2005. It currently has a total number of 52 (2023) employees. From the latest financial highlights, Taigen Biopharmaceuticals Holdings Limit (太景医药研发控股股份有限公司) reported a net sales revenue drop of 79.84% in Q3C2025. Its’ total assets recorded a negative growth of 17.12%. The net profit margin of Taigen Biopharmaceuticals Holdings Limit (太景医药研发控股股份有限公司) decreased by 554.65% in 2025.
Headquarters
7F, 138 Shin Ming Rd., Neihu Dist
Taipei City; Taipei City;
Contact Details: Purchase the Taigen Biopharmaceuticals Holdings Limit (太景医药研发控股股份有限公司) report to view the information.
Website: http://www.taigenbiotech.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service